Questioning Big Pharma can lead to surprising revelations.
Two years ago, I was frustrated when the FDA approved GLP-1s for children as young as 12. I feared it was another overreach by the pharmaceutical giants.
But today, my perspective has shifted.
I'm grateful for this tool in my daughter's life.
Here's what you can learn from my journey:
- The importance of keeping an open mind as new medical options become available
- How personal experiences can transform our views on healthcare
- The potential impact of GLP-1s on young patients' lives
It's fascinating how our understanding evolves with personal experiences. How open are you to changing your perspective when new information arises?
Internal medicine-pediatric physician Chrissie Ott discusses her article "When the pediatrician is the parent: a personal reckoning with childhood obesity."
SUBSCRIBE TO THE PODCAST https://www.kevinmd.com/podcast
